Dan has five years’ experience in market access as a health economist. He has worked in a broad variety of disease areas which warrant different technical approaches, ranging from chronic liver diseases to neurological disorders and blood cancers. Dan is experienced in the development of economic models from the early disease modelling stage through to highly specialised models for HTA submissions. Techniques that Dan has used to develop these models include Markov models, partitioned survival models, and discrete event simulation.
Dan has a first-class honours BSc in Cell Biology from the University of Lancaster, an MPhil in Neuroscience from the University of Manchester, and an MSc in Health Economics and Decision Modelling from the University of Sheffield.